CRISPR gene therapy seems to cure dangerous inflammatory condition
Nine out of ten people in a trial of a CRISPR treatment for potentially life-threatening inflammatory reactions seem to have been cured
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nine out of ten people in a trial of a CRISPR treatment for potentially life-threatening inflammatory reactions seem to have been cured
A new technology to increase the visibility of cancer cells to the immune system using CRISPR has been developed and could lead to a new way to treat cancer.
Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year.
InnovationRx is your weekly digest of healthcare news. Sign up!
Crispr recently marked a major milestone in medicine. But it's not time for a victory lap—the race is just beginning.